OC-0049: Trends in the use of postoperative radiotherapy following mastectomy: a population-based study  by Corradini, S. et al.
S20                                                                                     ESTRO 35 2016 
 _____________________________________________________________________________________________________ 
H3K4Me1, H3K4Me3 and H3K27Ac as well as presence of CpG 
islands were used to identify methylated regulatory 
elements. 
 
Results: Nineteen men and 6 women, with a median age of 
69 years, were included. Ten were current smokers, 14 ex-
smokers (stopped more than 4 weeks before surgery) and 1 
non-smoker. Fourteen patients had adenocarcinoma, eleven 
patients had squamous cell carcinoma. When compared to 
distant lung tissue, gene expression of PD-L2, HGF, VEGFR2 
and VEGFR3 were downregulated in tumor tissue. PD-L1 
expression was also downregulated in tumor tissue, but only 
in active smokers. For PD-L2, HFG, VEGFR2 and VEGFR3, 
methylation data shows a clear hypermethylation pattern in 
the promoter and enhancer regions of tumor tissue, which is 
conform the results of the transcriptome sequencing. 
Qualitative results of the expression and methylation data 
are depicted in figure 1. 
 
 
Conclusion: Our results show a lower expression of PD-L1 in 
tumors of active smokers. PD-L2, VEGFR2 and VEGFR3 and 
HGF have a lower expression in tumors overall. Methylation 
data confirms these findings. The therapeutic ratio with 
targeted treatment might be narrow as a result of this higher 
expression in distant lung tissue and in the case of immune 
checkpoint inhibitors, increase the chance of pneumonitis. 
 
OC-0048  
Tumor microenvironment response and bone marrow cell 
migration after pulsed radiotherapy 
J.L. Kane
1Beaumont Health, Radiation Oncology, Royal Oak MI, USA 
1, S.A. Krueger1, A. Hanna1, T.R. Raffel2, G.D. 
Wilson1, G.J. Madlambayan2, B. Marples1 
2Oakland University, Biology, Rochester, USA 
 
Purpose or Objective: Recent studies have shown that 
alterations in the pattern of radiation delivery, such as 
pulsed radiotherapy (PRT), can produce significant changes 
to the tumor microenvironment. Given the positive effects of 
PRT on maintaining tumor vasculature, we hypothesized that 
PRT treatment would allow tumor microenvironments to 
remain more oxygenated and result in better overall tumor 
killing compared with SRT. We further postulated that this 
effect would be associated with decreased tumor hypoxia, 
leading to lower vascular endothelial growth factor (VEGF) 
and stromal derived factor-1 alpha (SDF-1α) production and 
subsequently lower recruitment of bone marrow derived cells 
(BMDCs) in PRT-irradiated tumors.  
 
Material and Methods: Subcutaneous Lewis lung carcinoma 
(LLC) tumors were established in C57BL/6 mice. Tumors were 
allowed to grow to 100-200mm3 before irradiation with a 160 
kVp Faxitron cabinet (HVL: 0.77 mm Cu) using a dose rate of 
0.69 Gy/min. SRT or PRT was given to 20 Gy at 2 Gy/day 
using a 5 day-on, 2 day-off schedule to mimic clinical 
delivery. Tumors were harvested 2-3 days post treatment. 
Radiation-induced changes in the tumor microenvironment 
were examined using flow cytometry and antibody-specific 
histopathology. Normal tissue effects were determined using 
non-invasive 18F-FDG PET/CT and MR imaging after naïve 
animals were given whole-lung irradiation to 40 Gy using the 
same 2 Gy/day regimens.  
 
Results: PRT was more effective than SRT at reducing tumor 
growth rate (0.24±0.02mm3/day and 0.67±0.06mm3/day 
respectively; p<0.0001). Histopathology analysis showed a 
significant reduction in the levels of Ki-67 (13±8%), hypoxia 
(8±1%), VEGF (3.5±1%) and SDF-1α (4.2±1.5%) as well as a 
concomitant decrease in CD45+ BMDC migration (7.8±2.2%) 
after PRT when compared to SRT. Higher vessel density was 
also observed in PRT irradiated tumors. No short-term 
differences were observed in normal lung tissue after PRT or 
SRT although all irradiated animals demonstrated higher 
levels of inflammation than controls. 
 
Conclusion: Using a rapidly proliferating LLC allograft model, 
we have found evidence for improved tumor killing with PRT 
relative to SRT due to vascular maintenance. PRT irradiated 
tumors exhibited slower growth rate and reduced hypoxia 
coincident with loss of supportive mechanisms utilized by 
tumors in low oxygen microenvironments, such as 
angiogenesis and recruitment of BMDCs. This study 
demonstrates the efficacy of PRT and highlights the 
importance of microenvironment responses during tumor 
radiotherapy. We conclude that PRT represents an improved 
treatment strategy that may result in better overall patient 
outcomes with little alteration in normal tissue toxicity. 
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Purpose or Objective: The objective of this population-
based study was to provide an overview on trends and 
changing patterns in the adoption of postmastectomy 
radiotherapy (PMRT) over a 25-year period, and to validate 
the effectiveness of postoperative radiotherapy. Focused 
attention was given to disparities and barriers related to the 
use of postoperative radiotherapy in nodal positive disease 
and elderly patients. 
 
Material and Methods: The study included epidemiological 
data of 16,675 patients diagnosed with invasive breast cancer 
from 1988 to 2012, within the catchment area of the Munich 
Cancer Registry. Use of PMRT, local recurrence free survival 
(LRFS), cumulative incidence (CI) of time to local recurrence, 
relative survival and conditional overall survival (cOS), were 
analysed for different time periods (1988-1997 and 1998-
2012). Factors predicting the use of postoperative 
radiotherapy were analysed using multivariate logistic 
regression. 
 
Results: Use of PMRT was associated with significant 
improvements in local control, with a 10-year LRFS of 88.9% 
with PMRT vs. 84.1% following mastectomy alone (p<0.001). 
After adjusting for age, tumour characteristics and other 
therapies, the Cox-regression analysis for LRFS identified 
PMRT as an independent predictor for improved local control 
(hazard ratio [HR]: 2.145; 95% CI: 1.787-2.574, p<0.001). 
Patients with 1-3 involved lymph nodes had a 10-year CI of 
time to local recurrence of 13.7% following mastectomy 
alone, compared to 6.5% following PMRT (p= 0.001). 
Comparable findings were obtained for the subgroup of 
patients presenting with ≥ 4 positive lymph nodes – 
presenting with 17.8% 10-year CI of time to local recurrence 
in the mastectomy only group, compared to 8.2% in the PMRT 
group (p<0.001). All effects were smaller or extinct in elderly 
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patients aged ≥ 70 years. On multivariate analysis for cOS, no 
advantage for PMRT was detected (HR: 1.084; 95% CI:0.986-
1.191, p=0.095). Variables favouring the use of postoperative 
radiotherapy on multivariate logistic regression analysis 
included young age (p<0.001), large tumour size (pT3/4) 
(p<0.001), positive resection margin (p<0.001), and positive 
nodal status (p<0.001). High-risk patients with ≥ 4 positive 
lymph nodes who underwent mastectomy in 1998-2012 had a 
significant increased likelihood of receiving PMRT (OR 6.245) 
as compared to patients treated in the early period of 
analysis, from 1988-1997 (OR 2.837). 
 
Conclusion: The present study was useful in providing a 
window on the adoption of PMRT in a large population-based 
cohort, and to determine trends over time, as well as to 
characterize and quantify the outcome in clinical practice. A 
significant shift in indications for PMRT was registered, 
especially for high-risk patients with ≥ 4 positive lymph 
nodes. Moreover, the present findings track a substantial 
variation and apparent underuse of PMRT within the 
vulnerable population of elderly patients aged ≥ 80 years.  
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Purpose or Objective: Phase III randomised controlled trials 
and subsequent evidence-based treatment guidelines suggest 
that breast hypofractionation has low toxicity and similar 
cancer outcomes compared to patients undergoing standard 
fractionation. However, uptake of hypofractionation has not 
been universal. The aim of this study was to investigate the 
uptake of hypofractionation regimens in all public radiation 
oncology facilities in NSW.  
 
Material and Methods: Data from the NSW Clinical Cancer 
Registry were extracted, cleaned and verified. The inclusion 
criteria included those patients that are node negative breast 
cancer (TNM stage I or IIA), year of diagnosis between 2007 to 
2012, year of treatment between 2008 and 2012 and received 
external beam radiotherapy in a public radiotherapy facility. 
Data extracted included dose and fractionation type, patient 
age at first fraction, distance from treatment facility, year of 
diagnosis, year of treatment, laterality of treatment and 
department of treatment. In this analysis, standard 
fractionation was defined as dose per fraction of between 1.8 
– 2.4 Gy per fraction and hypofractionation as above 2.4 Gy 
per fraction. Univariate and multivariate analyses were 
performed to assess which factors predict for 
hypofractionation use.  
 
Results: Of the 6066 early breast cancer patients fulfilling 
the study criteria, 3947 patients (65%) had standard 
fractionation and 2119 patients (35%) received 
hypofractionation in 14 public radiotherapy centres in NSW. 
There was a wide spread of fractionation used across 
departments ranging from 6% to 92%. Hypofractionation use 
exceeded 50% in only 4 departments. Statistically significant 
factors to predict for hypofractionation use were increasing 
patient age, right sided breast cancer, further distance from 
home to the treating facility, more recent treatment, facility 
and clinician treating.  
 
Conclusion: While hypofractionation has become more 
common across NSW, there remains a substantial proportion 
of patients for whom hypofractionation would be considered 
appropriate who are not receiving hypofractionation. This has 
also been found to be the case in US studies, although we 
believe we are the first to identify laterality as an indicator. 
Understanding factors that may predict standard 
fractionation use might assist in developing strategies to 
address the issue. Hypofractionation for early breast cancer 
being adopted more widely would lead to greater patient 
convenience, better resource efficiencies in radiation 
oncology departments and perhaps even increase the use of 
post-lumpectomy radiotherapy, as some patients might 
currently forego radiotherapy due to the perceived 
inconvenience of standardly fractionated radiotherapy. 
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Purpose or Objective: To investigate inter-operator and 
inter-center variability in lymph node (LN) volume 
delineations in breast cancer (BC) nodal irradiation. 
 
Material and Methods: The study was conducted by the 
Italian Society of Radiation Oncologists (AIRO) - Breast Cancer 
Working Group. For each center, 3 radiation oncologists (ROs) 
with different expertise were involved: 1 junior (J), 1 senior 
(S) not dedicated to BC, and 1 senior (E) expert in BC. The CT 
series of 3 patients at different levels of complexity were 
selected: 1 with simple anatomy (P1), 1 obese (P2) and 1 
with impaired arm mobility (P3). ROs were asked to contour 
axillary nodes, as follows: I level (L1), II level (L2) and III 
level, the latter was further divided into infra (L3) and 
supraclavicular (L4) nodes on CT images by applying 
guidelines on breast contouring released by AIRO. The inter-
category and the inter-center variability were investigated, 
by evaluating the variability in volume size, structure overlap 
(measured as Dice similarity coefficient, DSC), and average 
Hausdorff distance (AHD) between contours. 
 
Results: Thirty-nine ROs from 14 centres participated and 
468 contours were obtained. Firstly, the analysis was focused 
on volume size. By comparing the operators, E-ROs contoured 
slightly larger volumes than S-ROs and J-ROs, with no 
statistically significant differences. Conversely, statistically 
significant differences were found in volume size when 
stratifying for patients (larger volumes were obtained for P2) 
and for LN levels (in order of size: L1, L4, L2, L3 – L1 being 
the largest and L3 the smallest). Secondly, descriptive and 
statistical intra-group analysis showed that all the 3 principal 
factors (different expertise, LN level and patient) 
contributed to inter-operator variability. When analysing 
DSC, poor agreement was found among ROs stratified for 
expertise (Fig. 1a) and the differences between S-ROs and 
the other groups were statistically significant. Considering 
the LN levels (Fig. 1b), the highest concordance was found in 
the contouring of L1 and L4 levels and the lowest for L3 
(p<0.05). Moreover, inter-operator consistency dramatically 
decreased as patient complexity increased (Fig. 1c). 
Consistent results were found in the analysis of AHD. Finally, 
considering the inter-center variability, statistically 
significant differences were found in 38.5% of comparisons 
when considering intra-center median DSC (Fig. 1d) and in 
33% of comparisons when considering intra-center median 
AHD.  
 
